Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
cancer
5
×
ipo
5
×
life sciences
national blog main
new york blog main
5
×
fda
national top stories
new york top stories
san diego blog main
san diego top stories
san francisco blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
venture capital
wisconsin blog main
wisconsin top stories
biogen
cancer immunotherapy
deals
deerfield management
drug development
drug discovery
europe blog main
What
ipo
5
×
medicines
bio
covid
new
plans
public
roundup
sciences
acquisitions
activity
advance
announced
approvals
biogen
biology
biotechs
ceo
clamped
club
collabs
companies
company
company’s
continued
course
crop
cytokine
daniel
deal
delays
developing
development
discover
drugs
economic
enhanced
exceeded
experimental
fast
Language
unset
Current search:
ipo
×
cancer
×
ipo
×
" new york blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M